Tuesday, November 24, 2020


Auditorium - Omni Hospital
Pulomas 7th floor
Pulomas Barat VI No. 20,
East Jakarta 13210


10:00 (GMT+7)


  1. Approval of the company plan to increase capital with Pre-emptive Rights (“HMETD”) through the limited public offering with HMETD in accordance with the OJK Regulation(“OJK”) No.32/POJK.04/2015 regarding the Capital Increase of Public Companies with Pre-emptive Rights as amended by OJK Regulation No.14/POJK.04/2019 ("OJK Regulation 32/2015").
  2. Approval of amendments to the provisions of Article 4 of the company Articles of Association, related to the Preemptive Rights, including an increase in the authorised and paid-up capital, and issued capital of the Company.
  3. Approval of the company plan to take over 99.9999% (ninety nine point nine nine nine nine percent) shares of PT Elang Medika Corpora owned by PT Elang Mahkota Teknologi Tbk with a transaction value of Rp 1,254,900,000,000, - (one trillion two hundred and fifty-four billion nine hundred million Rupiah), which is a Material Transaction as referred in OJK Regulation No. 17/POJK.04/2020 regarding the Material Transactions and changes in Business Activities ("OJK Regulation 17/2020").
  4. Approval of the change of the Board members composition
来源 #1
SAME - PT. Sarana Meditama Metropolitan Tbk

Rp 464

-16 (-3,45%)